Latest Global Markets News

Australian Agricultural Company Limited (AACo) reported a robust FY25 operating profit of $58.4 million, driven by increased meat and cattle sales volumes and strategic brand growth despite inflationary pressures.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.

Bell Financial Group delivered strong financial results for 2024, driven by growth in technology and product services, but early 2025 shows challenges from market volatility impacting core broking revenues.

Anatara Lifesciences has expanded its intellectual property footprint with a 20-year patent granted in Hong Kong for its GaRP gastrointestinal health product, following similar approvals in Europe and Australia. This milestone strengthens its commercial position in the lucrative global market for digestive health solutions.

International Graphite Limited has received encouraging feedback from the U.S. Department of Defense on its proposal for up to US$7.5 million in funding to advance its graphite mine-to-market strategy, potentially securing a vital supply chain from Western Australia to the U.S.

Australian Bond Exchange Holdings has completed a $683,180 private placement, issuing over 17 million shares to strengthen its financial position and support expansion and cost-cutting initiatives.

Navigator Global Investments has raised its FY25 earnings outlook, projecting a 17-22% increase in adjusted EBITDA driven by robust profit distributions from its diversified Partner Firms.

Proteomics International Laboratories has secured a key Chinese patent for its OxiDx oxidative stress test, broadening its intellectual property coverage across major global markets until 2039. This milestone reinforces the company’s position in precision diagnostics for sports and veterinary health.

GrainCorp reported a robust first half of FY25 with improved earnings and upgraded guidance, underpinned by strong East Coast grain volumes and operational resilience.

Austco Healthcare has landed a $2.1 million deal to supply its Tacera nurse call system for a major new patient and surgical tower at Toronto Western Hospital, marking a significant step in its North American expansion.

Insignia Financial updates the market on its acquisition talks, revealing Bain Capital's withdrawal due to global market volatility while discussions with CC Capital continue without certainty.

Orthocell has secured regulatory approval to sell its nerve repair product Remplir™ in Hong Kong well ahead of schedule, expanding its footprint across key global markets. This milestone complements recent clearances in the US, Canada, and Asia, positioning the company for significant growth in a multi-billion-dollar market.